Achieve Life Sciences ACHV
NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Achieve Life Sciences (ACHV) Net Margin (2010 - 2015)

Achieve Life Sciences' (ACHV) quarterly Net Margin came in at 20.5% in Q4 2015, up 94.74% on a QoQ basis from 389.5% in Q4 2012.

Analysis

Achieve Life Sciences (ACHV) Net Margin (2010 - 2015) Analysis & Trends

Achieve Life Sciences (ACHV) has 4 years of Net Margin data on file, last reported at 20.5% in Q4 2015.

  • Quarterly Net Margin changed N/A year-over-year to 20.5% in Q4 2015, while the trailing twelve-month figure through Mar 2016 was 6.26% (changed N/A YoY) and the FY2015 annual result came in at 6.8%, changed N/A from the prior year.
  • Net Margin climbed to 20.5% in Q4 2015, from 389.5% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 346.05% in Q2 2011 to a low of 1600.08% in Q4 2011.
  • A 3-year average of 284.04% and a median of 253.96% in 2011 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2011 — Net Margin sank 148012 bps — and 2012, when it surged 121058 bps.
  • Tracing ACHV's Net Margin over 3 years: stood at 1600.08% in 2011, then jumped by 76 bps to 389.5% in 2012, then soared by 95 bps to 20.5% in 2015.
  • The last three Net Margin figures came in at 20.5% (Q4 2015), 389.5% (Q4 2012), and 90.11% (Q3 2012), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 30.23%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 31.16%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -539.31%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.90%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 12.74%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 12.09%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -3.12%
10 Achieve Life Sciences 369.90 Mn 369.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -20.50%
Dec 31, 2012 -389.50%
Sep 30, 2012 90.11%
Jun 30, 2012 173.53%
Mar 31, 2012 -521.28%
Dec 31, 2011 -1,600.08%
Sep 30, 2011 -380.75%
Jun 30, 2011 346.05%
Mar 31, 2011 -253.96%
Dec 31, 2010 -119.97%
Sep 30, 2010 -141.24%
Jun 30, 2010 -343.68%